학술논문

Safety and efficacy of atogepant for the preventive treatment of episodic migraine in adults for whom conventional oral preventive treatments have failed (ELEVATE): a randomised, placebo-controlled, phase 3b trial
Document Type
Article
Source
In The Lancet Neurology April 2024 23(4):382-392
Subject
Primary Research
Articles
Language
ISSN
1474-4422